Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Avalo Therapeutics Inc (NQ: AVTX ) 12.96 -0.04 (-0.35%) Streaming Delayed Price Updated: 3:58 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Avalo Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa October 08, 2024 From Avalo Therapeutics Via GlobeNewswire Avalo Announces Participation in September Investor Conferences September 04, 2024 From Avalo Therapeutics Via GlobeNewswire AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024 August 12, 2024 AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates August 12, 2024 From Avalo Therapeutics Via GlobeNewswire Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 03, 2024 Via Benzinga The 3 Best Personalized Nutrition Stocks to Buy Now July 24, 2024 Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer July 16, 2024 From Avalo Therapeutics Via GlobeNewswire Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa July 09, 2024 From Avalo Therapeutics Via GlobeNewswire Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer June 24, 2024 From Avalo Therapeutics Via GlobeNewswire Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit June 17, 2024 From Avalo Therapeutics Via GlobeNewswire AVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats Revenue for Q4 2023 May 24, 2024 AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024 May 13, 2024 AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates May 13, 2024 From Avalo Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session April 29, 2024 Via Benzinga Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades April 16, 2024 Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 09, 2024 Via Benzinga Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 02, 2024 Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 02, 2024 Via Benzinga Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket April 02, 2024 Shares of VirTra, Inc. (NASDAQ: VTSI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter results. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 02, 2024 It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday! Via InvestorPlace Avalo Therapeutics Appoints Biotech Leaders to Board of Directors April 02, 2024 From Avalo Therapeutics Via GlobeNewswire Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket April 01, 2024 Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 01, 2024 It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Avalo Reports 2023 Financial Results and Provides Business Updates March 29, 2024 From Avalo Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session March 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 29, 2024 Via Benzinga Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results March 28, 2024 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session March 28, 2024 Via Benzinga Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 28, 2024 Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
